Valerian to Improve Sleep in Patients With Parkinson's Disease

Completed · Phase 2

Conditions studied: Insomnia, Parkinson's Disease

In brief

The purpose of this trial is to test the short-term effectiveness of valerian, a medicinal herb, to improve sleep in patients with Parkinson's disease (PD).

Key facts

Study ID

NCT00070928

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

80

Starts

2000-09-01

Expected to finish

2006-06-01

Last updated by the study team

2006-07-26

Who can join

Age: 30 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Idiopathic Parkinson's disease
• Willing to undergo overnight, in-lab polysomnography
• Sufficient literacy to allow completion of sleep logs
• Stable doses and timing of all Parkinsonian medications during the course of the trial

You may not qualify if…

• Dementia
• Parkinsonism secondary to toxic, infectious, or other medical conditions
• History of stroke, cerebellar disease, or progressive supranuclear palsy
• History of liver or renal disease
• History of duodenal or bladder obstruction

Where it is running

• Emory University Medical School/Wesley Woods Hospital — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.